Nakayama Atsushi, Otani Akira, Inokuma Tsubasa, Tsuji Daisuke, Mukaiyama Haruka, Nakayama Akira, Itoh Kohji, Otaka Akira, Tanino Keiji, Namba Kosuke
Department of Pharmaceutical Sciences, Tokushima University, 1-78-1 Shomachi, Tokushima, 770-8505, Japan.
Research Cluster on "Innovative Chemical Sensing", Tokushima University, 1-78-1 Shomachi, Tokushima, 770-8505, Japan.
Commun Chem. 2020 Jan 9;3(1):6. doi: 10.1038/s42004-019-0250-0.
For the fluorescence imaging of biologically active small compounds, the development of compact fluorophores that do not perturb bioactivity is required. Here we report a compact derivative of fluorescent 1,3a,6a-triazapentalenes, 2-isobutenylcarbonyl-1,3a,6a-triazapentalene (TAP-VK1), as a fluorescent labeling reagent. The reaction of TAP-VK1 with various aliphatic thiols proceeds smoothly to afford the corresponding 1,4-adducts in high yields, and nucleophiles other than thiols do not react. After the addition of thiol groups in dichloromethane, the emission maximum of TAP-VK1 shifts to a shorter wavelength and the fluorescence intensity is substantially increased. The utility of TAP-VK1 as a compact fluorescent labeling reagent is clearly demonstrated by the labeling of Captopril, which is a small molecular drug for hypertension. The successful imaging of Captopril, one of the most compact drugs, in this study demonstrates the usefulness of compact fluorophores for mechanistic studies.
对于生物活性小分子化合物的荧光成像,需要开发不会干扰生物活性的紧凑型荧光团。在此,我们报道了一种荧光1,3a,6a - 三氮杂戊搭烯的紧凑型衍生物,即2 - 异丁烯基羰基 - 1,3a,6a - 三氮杂戊搭烯(TAP - VK1),作为一种荧光标记试剂。TAP - VK1与各种脂肪族硫醇的反应顺利进行,以高收率得到相应的1,4 - 加合物,而硫醇以外的亲核试剂不发生反应。在二氯甲烷中加入硫醇基团后,TAP - VK1的最大发射波长移至较短波长,且荧光强度大幅增加。通过对用于治疗高血压的小分子药物卡托普利进行标记,清楚地证明了TAP - VK1作为紧凑型荧光标记试剂的实用性。在本研究中,对最紧凑型药物之一卡托普利的成功成像证明了紧凑型荧光团在机理研究中的有用性。